Compare HeyElsa (ELSA) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HeyElsa vs Mira — how do they compare? HeyElsa trades at Rp839.16 (market cap Rp214,8M, Rp69,16M 24h volume), while Mira trades at Rp701.98 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: HeyElsa and Mira are close in size by market cap, and HeyElsa's circulating supply is 255,6M / 1B ELSA (26%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold HeyElsa for 6 Days and Mira for 22 Days on average.
| ELSA | MIRA | |
|---|---|---|
Market Cap | Rp214,8M | Rp226,43M |
Volume (24h) | Rp69,16M | Rp101,47M |
Circulating Supply | 255,6M / 1B ELSA (26%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 6 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HeyElsa (ELSA) is trading at Rp927.41 with a bearish technical signal, positioned near the pivot point of Rp924. The asset has a market cap of Rp239.34 million and a circulating supply of 255,600 tokens out of a maximum 1 million, indicating a 26% circulation rate. No major protocol updates or ecosystem developments were noted recently.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from support levels, but risks involve low market cap volatility and lack of recent fundamental catalysts. Investors should monitor trading volume and on-chain activity for signs of momentum shifts.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HeyElsa
HeyElsa is an AI crypto assistant that converts natural-language commands into optimized on-chain actions. It enables intent-based execution for tasks like swaps and staking, handles routing and risk checks, and supports multiple chains including Ethereum, Solana, and Base. The platform also offers MPC wallets and onboarding tools to simplify DeFi for new users.
Read more on ELSA →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
